4-Propylphenylboronic acid

We are 4-Propylphenylboronic acid CAS:134150-01-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name: 4-Propylphenylboronic acid
Other Name:
4-Propylphenylboronic acid
4-Propylbenzeneboronic acid
4-n-Propylphenylboronic acid
CAS No: 134150-01-9
MF: C9H13BO2
MW: 164.00900
Density: 1.05g/cm3
Boiling point: 299.1ºC at 760mmHg
Melting point: 89-97 °C(lit.)
Flash point: 134.7ºC
Refractive index: 1.516
UN Number: Not dangerous goods.
UN Proper Shipping Name: Not dangerous goods.
Transport hazard class: Not dangerous goods.
Packing group: Not dangerous goods.
 
Specification
Appearance: White powder
Assay: ≥98.0%
Water: ≤0.50%
 
Application
Be used as pharmaceutical intermediate, OLED intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

4-Propylphenylboronic acid


Related News: If the drug is in a syrup form, then the excipient is the liquid that has been used to make it as such.1-Fluoro-2,4-dinitrobenzene CAS:70-34-8 In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of “predictable” clinical value for life-threatening diseases for which effective treatment is not immediately available.7791-25-5 In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of “predictable” clinical value for life-threatening diseases for which effective treatment is not immediately available.Sulfato de hidroxilamina CAS:10039-54-0 In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of “predictable” clinical value for life-threatening diseases for which effective treatment is not immediately available.The primary endpoint of INSPIRE is overall survival. The trial continued beyond the pre-specified interim analysis and is nearing its conclusion.

Related Products
Product Name
View Details
4-chloroaniline View Details
3-(Chloromethyl)heptane View Details
(2R)-4-benzyl-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]morpholin-3-one manufacturer 3-(Methylthio)butanal manufacturer Methyl 2-methyl-3-furyl disulfide manufacturer Benzenesulfinic Acid Sodium Salt manufacturer 2-Fluoro-6-methylbenzaldehyde manufacturer